29089QAB1
Emergent Biosolutions Inc.
Could not find a ticker for this position, may be a filing error
A specialty biopharmaceutical company that makes medicines to protect against biological threats and opioid overdoses. Its best-known products include BioThrax, a vaccine against anthrax, and NARCAN, a nasal spray that reverses opioid overdoses and became the first naloxone product sold over the counter without a prescription. Founded in 1998 as BioPort, the company took over Michigan's anthrax vaccine facilities and later renamed itself Emergent BioSolutions, a nod to its role in helping people emerge from public health emergencies.
CONVERTIBLEUnderlying: EBSCUSIP: 29089QAB1HealthcareUS1 derivative reporter
2.875% Convertible Senior Notes due 2021
No tracked superinvestor held this security as stock in this period — only the derivative positions below reference it.
Derivative Reporters
Investor
Kind
13F reported value
Quantity
Change
